M
Masao Ishii
Publications - 3
Citations - 484
Masao Ishii is an academic researcher. The author has contributed to research in topics: Blood pressure & Hazard ratio. The author has an hindex of 3, co-authored 3 publications receiving 76 citations.
Papers
More filters
Journal ArticleDOI
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Kazem Rahimi,Zeinab Bidel,Milad Nazarzadeh,Emma Copland,Dexter Canoy,Rema Ramakrishnan,Ana-Catarina Pinho-Gomes,Mark Woodward,Amanda I Adler,Larry Agodoa,Ale Algra,Folkert W. Asselbergs,Nigel S Beckett,Eivind Berge,Henry R. Black,Frank P. Brouwers,Morris J. Brown,Christopher J. Bulpitt,Robert P Byington,William C. Cushman,Jeffrey Cutler,Richard B Devereaux,Jamie P. Dwyer,Ray Estacio,Robert Fagard,Kim Fox,Tsuguya Fukui,Ajay Gupta,Rury R. Holman,Yutaka Imai,Masao Ishii,Stevo Julius,Yoshihiko Kanno,Sverre E. Kjeldsen,John B. Kostis,Kizuku Kuramoto,Jan Lanke,Edmund J. Lewis,Julia B Lewis,Michel Lievre,Lars H Lindholm,Stephan Lueders,Stephen MacMahon,Giuseppe Mancia,Masunori Matsuzaki,Maria H Mehlum,Steven E. Nissen,Hiroshi Ogawa,Toshio Ogihara,Takayoshi Ohkubo,Christopher R. Palmer,Anushka Patel,MA Pfeffer,Bertram Pitt,Neil R Poulter,Hiromi Rakugi,Gianpaolo Reboldi,Christopher M. Reid,Giuseppe Remuzzi,Piero Ruggenenti,Takao Saruta,Joachim Schrader,Robert W. Schrier,Peter S. Sever,Peter Sleight,Jan A. Staessen,Hiromichi Suzuki,Lutgarde Thijs,Kenji Ueshima,Seiji Umemoto,Wiek H. van Gilst,Paolo Verdecchia,Kristian Wachtell,Paul K. Whelton,Lindon Wing,Yoshiki Yui,Salim Yusuf,Alberto Zanchetti,Zhen-Yu Zhang,Craig S. Anderson,Colin Baigent,Barry M. Brenner,Rory Collins,Dick de Zeeuw,Jacobus Lubsen,Ettore Malacco,Bruce Neal,Vlado Perkovic,Anthony Rodgers,Peter M. Rothwell,Gholamreza Salimi-Khorshidi,Johan Sundström,Fiona Turnbull,Giancarlo Viberti,Ji-Guang Wang,John Chalmers,Koon K. Teo,Carl J. Pepine,Barry R. Davis +98 more
TL;DR: In this paper, a meta-analysis of individual participant-level data from 48 randomised trials of pharmacological blood pressure lowering medications versus placebo or other classes of blood pressure-lowering medications, or between more versus less intensive treatment regimens, was performed.
Journal ArticleDOI
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Kazem Rahimi,Zeinab Bidel,Milad Nazarzadeh,Emma Copland,Dexter Canoy,Malgorzata Wamil,Jeannette Majert,Richard J McManus,Amanda I Adler,Larry Agodoa,Ale Algra,Folkert W. Asselbergs,N Beckett,Eivind Berge,Henry R. Black,Eric Boersma,Frank P. Brouwers,Morris J. Brown,Jasper J Brugts,Christopher J. Bulpitt,Robert P Byington,William C. Cushman,Jeffrey Cutler,Richard B Devereaux,Jamie P. Dwyer,Ray Estacio,Robert Fagard,Kim Fox,Tsuguya Fukui,Ajay Gupta,Rury R. Holman,Yutaka Imai,Masao Ishii,Stevo Julius,Yoshihiko Kanno,Sverre E. Kjeldsen,John B. Kostis,Kizuku Kuramoto,Jan Lanke,Edmund J. Lewis,Julia B. Lewis,Michel Lievre,Lars H Lindholm,Stephan Lueders,Stephen MacMahon,Giuseppe Mancia,Masunori Matsuzaki,Maria H Mehlum,Steven E. Nissen,Hiroshi Ogawa,Toshio Ogihara,Takayoshi Ohkubo,Christopher R. Palmer,Anushka Patel,MA Pfeffer,Bertram Pitt,Neil R Poulter,Hiromi Rakugi,Gianpaolo Reboldi,Christopher M. Reid,Giuseppe Remuzzi,Piero Ruggenenti,Takao Saruta,Joachim Schrader,Robert W. Schrier,Peter S. Sever,Peter Sleight,Jan A. Staessen,Hiromichi Suzuki,Lutgarde Thijs,Kenji Ueshima,Seiji Umemoto,Wiek H. van Gilst,Paolo Verdecchia,Kristian Wachtell,Paul K. Whelton,Lindon Wing,Mark Woodward,Yoshiki Yui,Salim Yusuf,Alberto Zanchetti,Zhen-Yu Zhang,Craig S. Anderson,Colin Baigent,Barry M. Brenner,Rory Collins,Dick de Zeeuw,Jacobus Lubsen,Ettore Malacco,Bruce Neal,Vlado Perkovic,Anthony Rodgers,Peter M. Rothwell,Gholamreza Salimi-Khorshidi,Johan Sundström,Fiona Turnbull,Giancarlo Viberti,Ji-Guang Wang,John Chalmers,Barry R. Davis,Carl J. Pepine,Koon K. Teo +101 more
TL;DR: Pharmacological blood pressure reduction is effective into old age, with no evidence that relative risk reductions for prevention of major cardiovascular events vary by systolic or diastolic blood pressure levels at randomisation, down to less than 120/70 mm Hg.
Journal ArticleDOI
Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials
Larry Agodoa,Ray Estacio,Robert W. Schrier,Jacobus Lubsen,John Chalmers,Jeffrey A. Cutler,Barry R. Davis,Lindon Wing,Neil R Poulter,Peter S. Sever,G. Remuzzi,Piero Ruggenenti,Steven E. Nissen,Lars H Lindholm,Tsuguya Fukui,Toshio Ogihara,Takao Saruta,Henry R. Black,Peter Sleight,Michel Lievre,Hiromichi Suzuki,Keith A.A. Fox,Liu Lisheng,Takayoshi Ohkubo,Yutaka Imai,Salim Yusuf,Christopher J. Bulpitt,Edmund J. Lewis,Matthew A. Brown,Colin N. A. Palmer,Ji-Guang Wang,Carl J. Pepine,Masao Ishii,Yoshiki Yui,Kizuku Kuramoto,M. Pfeff Er,Folkert W. Asselbergs,W. H. Van Gilst,B. Byington,Bertram Pitt,Barry M. Brenner,W. J. Remme,Dick de Zeeuw,Mahboob Rahman,Giancarlo Viberti,Koon K. Teo,Alberto Zanchetti,Ettore Malacco,G. Mancia,J.A. Staessen,Robert Fagard,Rury R. Holman,L. Hansson,John B. Kostis,Yoshihiko Kanno,Stephan Lueders,Masunori Matsuzaki,P. Poole-Wilson,Joachim Schrader,Kazem Rahimi,Craig S. Anderson,Neil Chapman,Rory Collins,Stephen MacMahon,Bruce Neal,Anthony Rodgers,Paul K. Whelton,Mark Woodward +67 more
TL;DR: Little evidence is found that selection of a particular class of blood pressure-lowering drug will lead to substantially different outcomes for individuals who are obese compared with those who are lean.